CHPA welcomes Wysong’s appointment as NACDS chief
Melville: “Mike is a champion of industry and a passionate leader; I know he will be outstanding in this new role.”
CHPA
CHPA honors Julie Aker for work advancing OTC medicines
“Julie has been at the center of some of the most important OTC switches of the past several decades, helping shape the science that gives regulators confidence and consumers greater access to self-care products.”
CHPA issues statement on California AB 230
"CHPA is disappointed that AB 2030, as signed into law, does not strike a better balance between our shared goal of protecting minors and preserving access to safe, beneficial products for adults who use them responsibly."
Supplement groups back drug preclusion reform bill
CHPA, AHPA and CRN say the legislation would clarify FDA drug preclusion rules and provide greater regulatory certainty for dietary supplements.
CHPA names 2026 Self-Care Marketing Awards finalists
Winners across six self-care marketing categories will be announced November 11 at the Health In Hand Foundation Gala in Philadelphia.
CHPA president and CEO Scott Melville to step down
Scott Melville will conclude a 16-year tenure during which CHPA expanded its reach across the broader self-care industry.
CHPA issues statement on nomination of Dr. Heidi Overton
"We are pleased the Administration is moving quickly to appoint a permanent leader of the FDA. Stable, science-based leadership is essential to a smooth-functioning FDA.”
CHPA and CBA push back against regulatory moves on food definitions and ingredient reviews
Both groups warning that the government's approach risks confusing consumers and disrupting product availability without a clear scientific basis.
CHPA marks International Self-Care Day
CHPA said self-care interventions save an estimated 1.3 billion hours and $31.8 billion in healthcare-related costs annually across North America.
CHPA welcomes Missouri law expanding OTC cold and allergy med access
New law raises the annual purchase limit for pseudoephedrine products while maintaining safeguards against misuse.
CHPA names new chair-elect and board members
“CHPA is fortunate to have exceptional industry leaders volunteer their time to help direct the association’s priorities and oversee its governance,” said Scott Melville, President and CEO of CHPA.
CHPA calls for FDA stability after Makary departure
The trade association said that the pace of leadership turnover at the FDA over the past year has created uncertainty among industry stakeholders.
CHPA lauds Tennessee as it modernizes cold and allergy restrictions, clearing path for online sales of PSE medicines
The new law modernizes access by enabling online sales of PSE-containing medicines and removing outdated barriers to purchase, while continuing to rely on Tennessee’s real-time electronic tracking system to prevent misuse.
CHPA highlights role of O-T-C meds at FDA public meeting
“OTC medicines are a cornerstone of self-care, enabling millions of Americans to safely and effectively manage common conditions without a prescription,” said CHPA's David Spangler.
CHPA opens 2026 Awards for OTC marketing innovations
The awards spotlight strategic innovation and execution across key categories, including digital marketing, multicultural and inclusive campaigns, shopper marketing, and product launches.
CHPA elects new members and names 2027 Chair-Elect at Annual Summit
“CHPA is privileged to be guided by outstanding industry leaders who volunteer their time and expertise to serve on our board of directors,” said CHPA President and CEO Scott Melville.